Oncologic Imaging

The Division of Oncologic Imaging explores the basic chemical and biochemical mechanisms underlying cancer and in particular how these can be exploited in preclinical and clinical cancer imaging. The laboratory studies focus on research which supports translational programs leading to clinical trials.
Our academic staff supervise graduate students and medical residents and teach in the undergraduate M.D. program, in graduate and undergraduate level courses in oncology and in the radiopharmaceutical sciences.
The eight principal investigators in Oncologic Imaging perform laboratory and clinical-based research at the Cross Cancer Institute. The research programs of fall into the categories of radionuclides production, radiochemistry, targeted tracer development, radiopharmacy, pharmacokinetics, radiation dosimetry, SPECT and PET imaging and involve a variety of academic disciplines that include cellular and molecular biology and health care economics.
Research initiatives are supported by basic and clinical research tools that include human imaging cameras for conventional radiopharmaceuticals and PET agents, a microPET animal camera, a library of clinical research molecular imaging PET probes, a fully equipped clinical production lab, a basic research lab, a wide spectrum of automated chemistry modules for preparation of clinical and research radiopharmaceuticals and radiochemicals and a high yield medical cyclotron for isotope production and development of novel radionuclides.  For information on the Edmonton Positron Emission Tomography (PET) Center visit